Annals of Diagnostic Pathology
Volume 10, Issue 5 , Pages 263-268, October 2006

Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation

  • Malisha R. Johnson, DO

      Affiliations

    • Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
  • ,
  • Daniel Del Carpio-Jayo, MD

      Affiliations

    • Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
  • ,
  • Pei Lin, MD

      Affiliations

    • Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
  • ,
  • Sergio Giralt, MD

      Affiliations

    • Department of Bone Marrow Transplantation, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
  • ,
  • Paolo Anderlini, MD

      Affiliations

    • Department of Bone Marrow Transplantation, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
  • ,
  • Richard E. Champlin, MD

      Affiliations

    • Department of Bone Marrow Transplantation, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
  • ,
  • Issa F. Khouri, MD

      Affiliations

    • Department of Bone Marrow Transplantation, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
  • ,
  • Saroj Vadhan-Raj, MD

      Affiliations

    • Department of Cytokine and Supportive Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
  • ,
  • L. Jeffrey Medeiros, MD

      Affiliations

    • Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
  • ,
  • Carlos E. Bueso-Ramos, MD, PhD

      Affiliations

    • Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 713 792 6328; fax: +1 713 794 1800.

Abstract 

Plasma cell leukemia (PCL) is a neoplastic disorder of plasma cells of which there are 2 forms, primary PCL and secondary PCL, the latter occurring in patients with a history of plasma cell myeloma. We describe 4 patients with primary PCL. In all cases, the bone marrow aspirate smears and biopsy specimens demonstrated a diffuse infiltrate of atypical plasma cells that were difficult to classify using morphologic criteria alone. Immunophenotypic studies showed that each case was positive for plasma cell–associated antigens (cytoplasmic immunoglobin, CD38, or CD138) and negative for CD20. Of 4 cases, 3 had complex karyotypes, including the t(11;14)(q13;q32) or del(11)(q13). Despite chemotherapy and the use of novel therapeutic agents and stem cell transplantation, all 4 patients had short survival.

Keywords: Plasma cell leukemia, Stem cell transplantation, Chemotherapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1092-9134(05)00218-2

doi:10.1016/j.anndiagpath.2005.12.011

Annals of Diagnostic Pathology
Volume 10, Issue 5 , Pages 263-268, October 2006